Assessing physicians' preferences on skin cancer treatment in Europe.
about
Imiquimod-induced apoptosis of melanoma cells is mediated by ER stress-dependent Noxa induction and enhanced by NF-κB inhibition.Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.Prevention of Photocarcinogenesis by Agonists of 5-HT1A and Antagonists of 5-HT2A Receptors.The patient journey: a report of skin cancer care across Europe.Pronounced local skin reaction to ingenol mebutate against actinic keratosis in kidney transplant recipient without systemic adverse events.Basal cell carcinomas without histological confirmation and their treatment: an audit in four European regions.Actinic keratosis: a cross-sectional study of disease characteristics and treatment patterns in Danish dermatology clinics.
P2860
Q36504317-99D0BA55-8E1D-4619-BE07-14AED0B36706Q37362082-25547CC8-3A3F-4091-85BE-4D1E11D425DBQ38318548-9AD08DA5-C252-4E74-8A03-FA35A0A218E0Q38566476-AA73F45F-54D0-4D3B-8F44-09C0ACC7E206Q39566310-3DA54E9E-76A6-4A34-A26B-5CF2ACF06F25Q42510985-A1425EBC-8A12-44F1-B6B7-A8AF490F76FAQ50568165-2B01002F-D4D9-460A-BCD2-3568EC989120
P2860
Assessing physicians' preferences on skin cancer treatment in Europe.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Assessing physicians' preferences on skin cancer treatment in Europe.
@en
Assessing physicians' preferences on skin cancer treatment in Europe.
@nl
type
label
Assessing physicians' preferences on skin cancer treatment in Europe.
@en
Assessing physicians' preferences on skin cancer treatment in Europe.
@nl
prefLabel
Assessing physicians' preferences on skin cancer treatment in Europe.
@en
Assessing physicians' preferences on skin cancer treatment in Europe.
@nl
P2093
P2860
P50
P1476
Assessing physicians' preferences on skin cancer treatment in Europe
@en
P2093
A Ruiz-de-Casas
B Hinrichs
E Altsitsiadis
E Stockfleth
EPIDERM Group
K Kalokasidis
L Ferrandiz
M Trakatelli
P2860
P356
10.1111/J.1365-2133.2012.11084.X
P407
P478
167 Suppl 2
P577
2012-08-01T00:00:00Z